Global Information
회사소개 | 문의 | 비교리스트

세계의 재생의료 시장 예측과 기회(2025년)

Global Regenerative Medicine Market By Therapy, By Application, By Material, By Cell, By Product, By Technique, By Distribution Channel, By Region, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 934759
페이지 정보 영문 117 Pages
가격
US $ 4,450 ₩ 5,070,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,209,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,767,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 재생의료 시장 예측과 기회(2025년) Global Regenerative Medicine Market By Therapy, By Application, By Material, By Cell, By Product, By Technique, By Distribution Channel, By Region, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 117 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 재생의료(Regenerative Medicine) 시장은 세포, 조직, 장기 수복 및 치환 또는 재생에서 사용이 증가하고 있으므로 2025년까지 CAGR로 두 자릿수의 성장이 예측됩니다. 또한 만성적 질환 및 유전적 질환의 높은 발생률, 줄기세포 기술의 출현, 고령화 인구의 증가 등이 재생의료 시장을 촉진하는 주요 요인의 일부입니다.

재생의료는 정상적인 기능을 회복 또는 확립하기 위해 인간 또는 동물의 세포, 조직 또는 장기를 치환, 조작 또는 재생하는 프로세스를 다룹니다. 이것은 또한 영구 손상된 장기의 해결책을 창출하기 위해서도 사용되고 있습니다. 이 의료는 관절염 및 당뇨병과 같은 몇몇 불치병의 치료에도 사용됩니다.

세계의 재생의료 시장에 대해 조사분석했으며, 시장 규모·점유율·예측, 부문별 분석, 경쟁 분석, 시장 동향의 변화, 신규 기회에 관한 정보를 정리하여 전해드립니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 세계의 재생의료 시장에 대한 COVID-19(신종 코로나바이러스 감염증)의 영향

제4장 개요

제5장 고객의 소리

제6장 세계의 재생의료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측

제7장 북미의 재생의료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 북미 : 국가별 분석

제8장 유럽의 재생의료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 유럽 : 국가별 분석

제9장 아시아태평양의 재생의료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 아시아태평양 : 국가별 분석

제10장 중동·아프리카의 재생의료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 중동·아프리카 : 국가별 분석

제11장 남미의 재생의료 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
  • 남미 : 국가별 분석

제12장 시장 역학

  • 촉진요인
  • 과제

제13장 시장 동향과 개발

제14장 경쟁 구도

제15장 전략적 제안

제16장 출판사와 면책사항

KSA 20.05.27

Global regenerative medicine market is expected to register a double digit CAGR through 2025 owing to their increasing use in repair, replacement or regeneration of cells, tissues and organs. Additionally, high prevalence of chronic & genetic dieses, emergence of stem cell technology and growing aging populations are some of the key factors driving the regenerative medicine market.

Regenerative medicines deal with process of replacing, engineering or regenerating human or animal cells, tissues or organs to restore or establish normal function. They are also being used to create solutions for organs that become permanently damaged. These medicines are also used in treatment of some uncurable dieses like arthritis and diabetes.

Increasing number of cancer patients, neurodegenerative, orthopedic, and other aging-associated disorders is creating a significant demand for regenerative medicine market globally. Various countries like United States, China and Japan are investing in stem cell research, which indicates a bright future for regenerative medicine manufacturers.

The global regenerative medicine market also faces some restraints like high treatment costs, stringent government regulations and operative inefficiency. High investment required for developing the medicine might also limit the market growth.

The market is segmented based on therapy, application, material, cell, product, technique, distribution channel and region. The application segment comprises of musculoskeletal disorders, wound care, oncology, neurology, ocular disorders, diabetes, cardiology and others. Out of them, the musculoskeletal segment is expected to dominate the market during the forecast years owing to growing use of regenerative medicines for treating musculoskeletal disorders and increasing number of orthopedic diseases. Based on material, the regenerative medicine market is segmented into synthetic material, biologically derived material, genetically engineered material and pharmaceutical. The biologically derived material dominated the regenerative medicine market in 2019 and is expected to further hold its position in the coming years due to its unique properties. This type of material promotes cellular interactions, increases proliferation and controls the manipulation of cellular behavior.

Major players operating in the global regenerative medicine market include Novartis AG, Vericel, Integra Lifesciences, Mimedx Group, Stryker, Wright Medical, Roche, Bristol-Myers Squibb, Allergan, Corline Biomedical, Cook Biotech, Pfizer, Baxter, Boehringer Ingelheim, Caladrius Biosciences, Takara Bio, Medtronic, Osiris Therapeutics, Kite Pharma, Organogenesis and others. Due to growing demand from Asia-Pacific region, the manufacturers are focusing on countries like India and China where geriatric population is increasing rapidly.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global regenerative medicine market.
  • To classify and forecast global regenerative medicine market based on therapy, application, material, cell, product, technique, distribution channel and regional distribution.
  • To identify drivers and challenges for global regenerative medicine market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global regenerative medicine market.
  • To conduct pricing analysis for global regenerative medicine market.
  • To identify and analyze the profile of leading players operating in global regenerative medicine market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global regenerative medicine market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Regenerative medicine manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to regenerative medicines
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global regenerative medicine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Therapy:

Cell-Based Immunotherapy & Cell Therapy

Gene Therapy

Tissue-Engineering

Immunomodulation Therapy

Blood Transfusion

Bone Marrow Transplantation

Plasma Rich Plasma Therapy

Prolotherapy

Others

  • Market, By Application:

Musculoskeletal Disorders

Wound Care

Oncology

Neurology

Ocular Disorders

Diabetes

Cardiology

Others

  • Market, By Material:

Synthetic Material

  • Biodegradable Synthetic Polymers
  • Scaffold
  • Artificial Vascular Graft Materials
  • Hydrogel Materials

Biologically Derived Material

  • Collagen
  • Xenogeneic Material

Genetically Engineered Material

  • Genetically Manipulated Cells
  • 3D Polymer Technology
  • Transgenic
  • Fibroblast
  • Neural Stem Cells
  • Gene-activated Matrices

Pharmaceutical

  • Small Molecules
  • Biologics
  • Market, By Cell:

Autologous

Allogenic

  • Market, By Product:

Biologic

Cell -based Medical Devices

Biopharmaceutical

Biomaterial

  • Market, By Technique:

Microfracture

Mosaicplasty

  • Market, By Distribution Channel:

Hospitals

Clinics

Online

Others

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global regenerative medicine market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Regenerative Medicine Market

4. Executive Summary

5. Voice of Customer

6. Global Regenerative Medicine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Therapy (Cell-Based Immunotherapy & Cell Therapy, Gene Therapy, Tissue-Engineering, Immunomodulation therapy, Blood transfusion, Bone marrow transplantation, Plasma rich plasma therapy, Prolotherapy, Others)
    • 6.2.2. By Application (Musculoskeletal Disorders, Wound Care, Oncology, Neurology, Ocular Disorders, Diabetes, Cardiology, Others)
    • 6.2.3. By Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, Pharmaceutical)
      • 6.2.3.1. By Synthetic Material (Biodegradable Synthetic Polymers, Scaffold, Artificial Vascular Graft Materials, Hydrogel Materials)
      • 6.2.3.2. By Biologically Derived Material (Collagen, Xenogeneic Material)
      • 6.2.3.3. By Genetically Engineered Material (Genetically Manipulated Cells, 3D Polymer Technology, Transgenic, Fibroblast, Neural Stem Cells, Gene-activated Matrices)
      • 6.2.3.4. By Pharmaceutical (Small Molecules, Biologics)
    • 6.2.4. By Cell (Autologous, Allogenic)
    • 6.2.5. By Product (Biologic, Cell -based Medical Devices, Biopharmaceutical, Biomaterial)
    • 6.2.6. By Technique (Microfracture, Mosaicplasty)
    • 6.2.7. By Distribution Channel (Hospitals, Clinics, Online, Others)
    • 6.2.8. By Region
    • 6.2.9. By Company

7. North America Regenerative Medicine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Therapy
    • 7.2.2. By Application
    • 7.2.3. By Material
    • 7.2.4. By Cell
    • 7.2.5. By Product
    • 7.2.6. By Technique
    • 7.2.7. By Distribution Channel
    • 7.2.8. By Country (United States; Canada; Mexico and Rest of North America)
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Regenerative Medicine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value & Volume
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Therapy
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Material
        • 7.3.1.2.4. By Cell
        • 7.3.1.2.5. By Product
        • 7.3.1.2.6. By Technique
        • 7.3.1.2.7. By Distribution Channel
    • 7.3.2. Canada Regenerative Medicine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value & Volume
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Therapy
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Material
        • 7.3.2.2.4. By Cell
        • 7.3.2.2.5. By Product
        • 7.3.2.2.6. By Technique
        • 7.3.2.2.7. By Distribution Channel
    • 7.3.3. Mexico Regenerative Medicine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value & Volume
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Therapy
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Material
        • 7.3.3.2.4. By Cell
        • 7.3.3.2.5. By Product
        • 7.3.3.2.6. By Technique
        • 7.3.3.2.7. By Distribution Channel

8. Europe Regenerative Medicine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Therapy
    • 8.2.2. By Application
    • 8.2.3. By Material
    • 8.2.4. By Cell
    • 8.2.5. By Product
    • 8.2.6. By Technique
    • 8.2.7. By Distribution Channel
    • 8.2.8. By Country (United States; Canada; Mexico and Rest of North America)
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Regenerative Medicine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value & Volume
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Therapy
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Material
        • 8.3.1.2.4. By Cell
        • 8.3.1.2.5. By Product
        • 8.3.1.2.6. By Technique
        • 8.3.1.2.7. By Distribution Channel
    • 8.3.2. Germany Regenerative Medicine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value & Volume
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Therapy
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Material
        • 8.3.2.2.4. By Cell
        • 8.3.2.2.5. By Product
        • 8.3.2.2.6. By Technique
        • 8.3.2.2.7. By Distribution Channel
    • 8.3.3. United Kingdom Regenerative Medicine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value & Volume
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Therapy
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Material
        • 8.3.3.2.4. By Cell
        • 8.3.3.2.5. By Product
        • 8.3.3.2.6. By Technique
        • 8.3.3.2.7. By Distribution Channel
    • 8.3.4. Italy Regenerative Medicine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value & Volume
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Therapy
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Material
        • 8.3.4.2.4. By Cell
        • 8.3.4.2.5. By Product
        • 8.3.4.2.6. By Technique
        • 8.3.4.2.7. By Distribution Channel
    • 8.3.5. Spain Regenerative Medicine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value & Volume
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Therapy
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Material
        • 8.3.5.2.4. By Cell
        • 8.3.5.2.5. By Product
        • 8.3.5.2.6. By Technique
        • 8.3.5.2.7. By Distribution Channel

9. Asia-Pacific Regenerative Medicine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Therapy
    • 9.2.2. By Application
    • 9.2.3. By Material
    • 9.2.4. By Cell
    • 9.2.5. By Product
    • 9.2.6. By Technique
    • 9.2.7. By Distribution Channel
    • 9.2.8. By Country (United States; Canada; Mexico and Rest of North America)
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. South Korea Regenerative Medicine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value & Volume
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Therapy
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Material
        • 9.3.1.2.4. By Cell
        • 9.3.1.2.5. By Product
        • 9.3.1.2.6. By Technique
        • 9.3.1.2.7. By Distribution Channel
    • 9.3.2. China Regenerative Medicine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value & Volume
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Therapy
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Material
        • 9.3.2.2.4. By Cell
        • 9.3.2.2.5. By Product
        • 9.3.2.2.6. By Technique
        • 9.3.2.2.7. By Distribution Channel
    • 9.3.3. Japan Regenerative Medicine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value & Volume
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Therapy
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Material
        • 9.3.3.2.4. By Cell
        • 9.3.3.2.5. By Product
        • 9.3.3.2.6. By Technique
        • 9.3.3.2.7. By Distribution Channel
    • 9.3.4. India Regenerative Medicine Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value & Volume
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Therapy
        • 9.3.4.2.2. By Application
        • 9.3.4.2.3. By Material
        • 9.3.4.2.4. By Cell
        • 9.3.4.2.5. By Product
        • 9.3.4.2.6. By Technique
        • 9.3.4.2.7. By Distribution Channel
    • 9.3.5. Australia Regenerative Medicine Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value & Volume
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Therapy
        • 9.3.5.2.2. By Application
        • 9.3.5.2.3. By Material
        • 9.3.5.2.4. By Cell
        • 9.3.5.2.5. By Product
        • 9.3.5.2.6. By Technique
        • 9.3.5.2.7. By Distribution Channel

10. Middle East and Africa Printing Ink Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Therapy
    • 10.2.2. By Application
    • 10.2.3. By Material
    • 10.2.4. By Cell
    • 10.2.5. By Product
    • 10.2.6. By Technique
    • 10.2.7. By Distribution Channel
    • 10.2.8. By Country (United States; Canada; Mexico and Rest of North America)
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Regenerative Medicine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value & Volume
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Therapy
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Material
        • 10.3.1.2.4. By Cell
        • 10.3.1.2.5. By Product
        • 10.3.1.2.6. By Technique
        • 10.3.1.2.7. By Distribution Channel
    • 10.3.2. Saudi Arabia Regenerative Medicine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value & Volume
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Therapy
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Material
        • 10.3.2.2.4. By Cell
        • 10.3.2.2.5. By Product
        • 10.3.2.2.6. By Technique
        • 10.3.2.2.7. By Distribution Channel
    • 10.3.3. UAE Regenerative Medicine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value & Volume
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Therapy
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Material
        • 10.3.3.2.4. By Cell
        • 10.3.3.2.5. By Product
        • 10.3.3.2.6. By Technique
        • 10.3.3.2.7. By Distribution Channel

11. South America Regenerative Medicine Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value & Volume
  • 11.2. Market Share & Forecast
    • 11.2.1. By Therapy
    • 11.2.2. By Application
    • 11.2.3. By Material
    • 11.2.4. By Cell
    • 11.2.5. By Product
    • 11.2.6. By Technique
    • 11.2.7. By Distribution Channel
    • 11.2.8. By Country (United States; Canada; Mexico and Rest of North America)
  • 11.3. South America: Country Analysis
    • 11.3.1. Brazil Regenerative Medicine Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value & Volume
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Therapy
        • 11.3.1.2.2. By Application
        • 11.3.1.2.3. By Material
        • 11.3.1.2.4. By Cell
        • 11.3.1.2.5. By Product
        • 11.3.1.2.6. By Technique
        • 11.3.1.2.7. By Distribution Channel
    • 11.3.2. Argentina Regenerative Medicine Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value & Volume
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Therapy
        • 11.3.2.2.2. By Application
        • 11.3.2.2.3. By Material
        • 11.3.2.2.4. By Cell
        • 11.3.2.2.5. By Product
        • 11.3.2.2.6. By Technique
        • 11.3.2.2.7. By Distribution Channel
    • 11.3.3. Colombia Regenerative Medicine Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value & Volume
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Therapy
        • 11.3.3.2.2. By Application
        • 11.3.3.2.3. By Material
        • 11.3.3.2.4. By Cell
        • 11.3.3.2.5. By Product
        • 11.3.3.2.6. By Technique
        • 11.3.3.2.7. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Company Profiles
    • 14.2.1. Novartis AG
    • 14.2.2. Vericel
    • 14.2.3. Integra Lifesciences
    • 14.2.4. Mimedx Group
    • 14.2.5. Stryker
    • 14.2.6. Wright Medical
    • 14.2.7. Roche
    • 14.2.8. Bristol-Myers Squibb
    • 14.2.9. Allergan
    • 14.2.10. Corline Biomedical
    • 14.2.11. Cook Biotech
    • 14.2.12. Pfizer
    • 14.2.13. Baxter
    • 14.2.14. Boehringer Ingelheim
    • 14.2.15. Caladrius Biosciences
    • 14.2.16. Takara Bio
    • 14.2.17. Medtronic
    • 14.2.18. Osiris Therapeutics
    • 14.2.19. Kite Pharma
    • 14.2.20. Organogenesis

15. Strategic Recommendations

16. About Us and Disclaimer

Back to Top
전화 문의
F A Q